Mid-term effectiveness, safety, and potential predictors of response of upadacitinib in patients with moderate-to-severe atopic dermatitis: a multicenter observational retrospective study

IF 2.6 4区医学 Q2 DERMATOLOGY

Anais brasileiros de dermatologia Pub Date : 2025-05-01 DOI:10.1016/j.abd.2024.10.009

Francisco Javier Melgosa Ramos , Carlos Abril Pérez , Santiago Guillén Climent , María Matellanes Palacios , Juncal Roca Ginés , Javier Sabater Abad , Eduardo Bernia Petit , Andrés Casanova Esquembre , Andrea Estébanez Corrales , Victor González Delgado

引用次数: 0

查看原文本刊更多论文

upadacitinib治疗中重度特应性皮炎的中期有效性、安全性和潜在预测因素：一项多中心观察性回顾性研究

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Anais brasileiros de dermatologia DERMATOLOGY-

CiteScore

2.40

自引率

0.00%

发文量

184

审稿时长

32 days

期刊介绍： The journal is published bimonthly and is devoted to the dissemination of original, unpublished technical-scientific study, resulting from research or reviews of dermatological topics and related matters. Exchanges with other publications may be accepted.